Cutaneous squamous cell carcinoma (cSCC), the second most common skin cancer, requires early and accurate detection to optimize clinical management. Fluorescence imaging has emerged as a non‐invasive and cost‐effective tool with high sensitivity for tumor diagnosis; however, existing probes for cSCC are limited in achieving rapid and specific imaging. In this study, we introduce FC‐1, a dual‐tandem activatable fluorescent probe designed for precise cSCC diagnosis by simultaneously targeting fibroblast activation protein α and cathepsin C (CTSC). This dual‐locked activation strategy effectively reduces nonspecific signals in normal tissues while enhancing diagnostic specificity. In vivo studies in SCC‐7 xenografted mice demonstrated FC‐1's ability to visualize subcutaneous tumors with high sensitivity and specificity. Moreover, FC‐1 enabled clear differentiation between cSCC and keloids. The probe's dual‐activation mechanism and robust performance underscore its potential as a clinically translatable tool for early cSCC detection and differential diagnosis.
Enzyme‐activatable dual‐locked fluorescent probe for precision imaging of cutaneous squamous cell carcinoma
Yanhua Li,Shan Zuo,Yushi Chen,Junliang Zhou,Ling Shi,Lin Yuan
Published 2025 in Smart Molecules
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Smart Molecules
- Publication date
2025-09-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-37 of 37 references · Page 1 of 1
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1